Actelion Pharmaceuticals Ltd

Actelion Pharmaceuticals Ltd is located in Allschwil, Switzerland on Gewerbestrasse 16. Actelion Pharmaceuticals Ltd is rated 4.4 out of 5 in the category healthpharmaceutical company in Switzerland. Actelion Pharmaceuticals Ltd. Toggle navigation Home Sitemap Legal statements Cookies policy Patent marking Privacy policy About Actelion Actelion today Our Products History Our Strategy Values Target diseases Pulmonary arterial hypertension Digital ulcers Niemann-Pick Type C Type 1 Gaucher disease Actelion worldwide Our responsibilities Serving patients Media Media Releases Social Media Investors News archive Corporate reports Stock information Careers Actelion today FAQ Privacy policy Contact Operative Affiliates Webmaster COMMITTED TO PAH - TODAY AND TOMORROW Learn more Standing with the pulmonary arterial hypertension (PAH) community through COVID-19 The COVID-19 pandemic is an unprecedented health threat that is affecting the global population. People living with PAH are extremely vulnerable and may be more likely to be at high-risk of severe illness if they contract the virus. During this time, medical routines and appointments have adapted to ensure patient safety and ease the current burden on global healthcare systems. To the physicians, nurses and carers who are on the frontline of this pandemic, we thank you for your service and increased contribution to the welfare of the global population. We remain here to support you as best we can to serve the PAH community. If you, a family member or a friend have PAH, we understand that during this time of uncertainty you may be concerned about the availability of treatment. Please be assured that, at Actelion, we are committed to maintaining our supply chain so that the availability of treatment remains stable. We urge you to continue to stay safe by following government advice and maintaining social distancing rules. For more information or support on living with PAH during the COVID-19 pandemic, please reach out to your local patient advocacy group and/or your treating physician. We stand with you all during this time. We are with you until PH isn’t.   Target diseases Actelion’s products and late-stage development compounds target a number of different diseases. Learn more Contact Learn more Twitter Our Global Markets Actelion has subsidaries in more than 30 countries, covering all major pharmaceutical markets worldwide.   Select an affiliate website Australia Brazil Japan Korea Mexico Spain UK & Ireland United States Contact Actelion Pharmaceuticals Ltd Gewerbestrasse 16 CH-4123 Allschwil Switzerland Contact Us | Janssen How To Get To Actelion Viewing options Please  note that product information contained on this website may not necessarily comply with local product information. You are solely responsible to obtain country specific documentation. Last update: 246.2020 Legal statements|Cookies policy|Privacy Policy|Do Not Sell My Personal Information|Sitemap|Actelion Worldwide|Webmaster Cookie Settings Copyright © 2019 Actelion Pharmaceuticals Ltd